O’Neill et al. [4] conducted a study to evaluate the effects of a short and long-term screening program using endoscopic ultrasound and or MRI for pancreatic cancer in a high-risk group (FPC/ BRCA2). The gene discussed is BRCA2; the disease is pancreatic neoplasm.